Quantcast
Last updated on April 16, 2014 at 8:06 EDT

Latest hepatitis C Stories

2013-05-22 16:25:42

May 23, 2013, is Hepatitis B and C Testing and Awareness Day in the U.S. House of Representatives. ALEXANDRIA, Va., May 22, 2013 /PRNewswire/ -- Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans. More than 75 percent of those with hepatitis C are unaware they have the virus. Hepatitis B and C Testing and Awareness Day in the U.S. House of Representatives will take place at 10:00 am - 2:00 pm in the Rayburn Foyer of the Rayburn House Office...

2013-05-21 12:28:24

Saint Luke's Liver Disease Management Center says testing is key to saving lives, 'silent infection' rampant among baby boomers KANSAS CITY, Mo., May 21, 2013 /PRNewswire-USNewswire/ -- If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening. Hepatitis C is a contagious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The...

2013-05-21 08:29:31

ORLANDO, Fla., May 21, 2013 /PRNewswire/ -- Janssen R&D Ireland (Janssen) today announced primary efficacy and safety results from the global Phase 3 PROMISE study demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 79 percent of treatment-experienced genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when...

2013-05-15 23:20:25

New panels provide manufacturers with material from a variety of donor genotypes and recent collection periods. Milford, Massachusetts (PRWEB) May 15, 2013 SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, announced it has launched three new ACCUVERT seroconversion panels and one new ACCUSET performance panel. These product additions expand the company´s offerings...

2013-05-13 23:03:25

CDC estimates “silent killer” affects five million Americans. Camden, NJ (PRWEB) May 13, 2013 When 57-year-old Vineland resident Rafael Roman was hospitalized at a South Jersey medical center with liver failure one year ago, his doctor told him there was nothing that could be done for him. “He told me I´d be lucky to make it to the end of the week,” says Roman, a father of five. “I said to him, ℠You know it´s Thursday,...

2013-05-13 08:28:47

RARITAN, N.J., May 13, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease. Hepatitis C virus...

2013-05-13 08:27:15

However, Recent Changes in Brazil and Argentina are Expected to Drive a Shift in Treatment of HCV Genotype 1 Infections, According to a New Report From Decision Resources BURLINGTON, Mass., May 13, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of hepatitis C virus (HCV) patients in Brazil, Mexico and Argentina rely entirely on government-sponsored medical programs to...

2013-05-07 23:04:03

MedSpring Urgent Care offers free screenings in May. Austin, TX (PRWEB) May 07, 2013 Many baby boomers´ bodies may be harboring a silent killer: Hepatitis C. In fact, the federal Centers for Disease Control (CDC) recommends testing for anyone born between 1945 and 1965 as early diagnosis and treatment can help prevent liver damage, cirrhosis, liver cancer and other complications. In recognition of Hepatitis Awareness month, MedSpring is offering baby boomers, those born between...

2013-05-07 16:28:32

SAN DIEGO, May 7, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. Through the publication of CEO notes, I seek to provide shareholders and other interested parties with a level of corporate transparency often absent in the microcap marketplace. In recent notes, I reviewed various topics, including emerging opportunities in cancer and the expansion of our government contract program to create a sepsis...

2013-05-07 11:03:24

Scientists show potential impact of therapy in reducing transmission in UK, Canada and Australia Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) — a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. 1 New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could...


Latest hepatitis C Reference Libraries

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (1 articles) »